Actithera

Series-A
actithera.com Biotech & Healthcare Cambridge, United States Founded 2021 1-10
Total Funding $75.5M
Latest Round $75.5M Series-A
Last Announced Jul 9, 2025
Investors 9 Backers
Decision Makers 1 Verified

About Actithera

Actithera is a molecular radiotherapeutic company that develops radioligand therapies.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Cambridge, United States
Year Founded 2021
Team Size 1-10
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website actithera.com
Domain Registered Date Jul 12, 2021

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Raised $75,500,000 · Series-A

    fundraisingfox.com

  2. Milestone

    Website domain registered

    actithera.com

  3. Milestone

    Company founded

    Cambridge, United States

Investors & Backers

9
4BIO Capital
Arkin Bio Ventures
Bioqube Ventures
Hadean Ventures
Innovestor
Investinor
M Ventures
Sofinnova Partners
Surveyor Capital

Funding History

1 Round
Series-A · Jul 9, 2025

Founders & Leadership

2

Andreas Goutopoulos

Founder

Work email & phone locked Unlock →

Darshan Dalal

Chief Medical Officer

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts